OpenAI is moving methodically into regulated verticals and building the institutional scaffolding that precedes market consolidation. Boston Children's deploying GPT technology for rare disease diagnosis signals serious clinical validation; Braintrust's use of Codex with GPT-5.5 for engineering workflows shows the company is extending developer capture beyond chat interfaces; Rosalind Biodefense, with its vetted access model and government partnerships, establishes OpenAI as the trusted infrastructure layer for sensitive applications where regulatory approval and institutional relationships matter more than open competition. The playbook document on third-party evaluations is particularly telling, it's not a framework for industry standards but a guide for how to evaluate OpenAI's own systems, which amounts to OpenAI defining the criteria by which it will be judged. Meanwhile, AMD and Hugging Face are operating in the infrastructure layer, optimizing for the hardware and engineering problems that become relevant only after frontier models are deployed at scale. AMD's work on speculative decoding acceleration and quantum simulation suggests a company positioning itself as the compute partner to whoever wins the model wars, while Hugging Face's profiling guide is foundational tooling, necessary but secondary to the strategic positioning happening upstream. The pattern is clear: OpenAI is securing regulated use cases and government relationships; infrastructure players are optimizing for whoever comes out ahead.
Sloane Duvall
A curated reference of models from major AI labs, with open/closed weight status, input modalities, and context window size. American labs tend towards closed weights models and Chinese labs tend toward open weights models.
None
None
None
None
None
None
None